Similar articles

• Depletion of lymphoid tissues by tilorone. Ultrastructure and synergistic interaction with antilymphocyte serum.

  Levine S, Cacho P, Sowinski R, Thelmo WL. Levine S, et al. Am J Pathol. 1983 May;111(2):174-83. Am J Pathol. 1983. PMID: 6601914 Free PMC article.
• Selective depletion of thymus dependent areas in lymphoid tissue by tilorone.

  Levine S, Gibson JP, Megel H. Levine S, et al. Proc Soc Exp Biol Med. 1974 May;146(1):245-8. doi: 10.3181/00379727-146-38079. Proc Soc Exp Biol Med. 1974. PMID: 4545285 No abstract available.
• The interferonogenic agent tilorone as a modulator of GvH reaction in mice.

  Zschiesche W, Slavina E, Leipunskaya I. Zschiesche W, et al. Arch Immunol Ther Exp (Warsz). 1977;25(5):725-30. Arch Immunol Ther Exp (Warsz). 1977. PMID: 23088
• T-cell differentiation in the rabbit. II. Con A and PHA response of thymus, spleen and lymph node cells and of thymus subpopulations; influence of dexamethasone treatment.

  Roholl PJ, Al B, Hoeben KA, Leene W. Roholl PJ, et al. Thymus. 1983 Apr;5(3-4):167-78. Thymus. 1983. PMID: 6349021 Review.
• Tilorone and related bis-basic substituted polycyclic aromatic and heteroaromatic compounds.

  Levin RH, Albrecht WL. Levin RH, et al. Prog Med Chem. 1981;18:135-90. doi: 10.1016/s0079-6468(08)70319-9. Prog Med Chem. 1981. PMID: 7045982 Review. No abstract available.